Search
for
Sort by
Research 30 of 1000+
- Immune therapies for alopecia areata: evidence and new perspectives
- Toxic Side Effects of Targeted Therapies and Immunotherapies Affecting the Skin, Oral Mucosa, Hair, and Nails
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Dendritic cell subsets in alopecia areata: focus on plasmacytoid dendritic cells and Langerhans cells in immune imbalance and therapeutic implications
- 572 Development of immunotherapies targeting TCR-Vβ2 for treatment of cutaneous T cell lymphoma
- Immunotherapies
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse
- Topical immunotherapies
- Unraveling Vitiligo: From Immune Mechanisms to Promising Therapeutic Strategies
- Modulating immune responses in alopecia: therapeutic insights and potential targets of antisense oligonucleotides
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- Systemic immunotherapies
- Therapeutic small extracellular vesicles from key human stem and immune cellular sources: A review
- Recent Development in NSCLC Immunotherapies: Mechanisms, Advantages and Research Findings
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- The hair follicle as a neuro-immuno-endocrine organ: Implications in hair disorders and regenerative therapies
- Extra Virgin Olive Oil as Nutritional Therapeutic Immuno-Enhancer
- Identifying key components and therapeutic targets of the immune system in hidradenitis suppurativa with an emphasis on neutrophils
- The Future of Systemic Lupus Erythematosus Treatment: The Promise of Selective Immunotherapies, Anifrolumab and Belimumab, Compared to Blanket Immunosuppressives
- LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment
- Zinc as an essential element for normal immune reactions and as a therapeutic agent for autoimmune diseases
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- A novel immune competent murine hypertrophic scar contracture model: A tool to elucidate disease mechanism and develop new therapies
- IMMUNOTHERAPY OF CANCER: IMMUNE CHECKPOINT BLOCKERS, VACCINES AND ADOPTIVE T CELL THERAPIES
- Hair vaccine: Myth or future therapeutic reality? Immunopharmacological perspectives on immune-regenerative strategies for hair loss
- Macrophages as central mediators of sympathetic neuro-immune interplay in autoimmunity
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors